BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36439629)

  • 1. Irisin reduces bone fracture by facilitating osteogenesis and antagonizing TGF-β/Smad signaling in a growing mouse model of osteogenesis imperfecta.
    Sun B; Wu H; Lu J; Zhang R; Shen X; Gu Y; Shi C; Zhang Y; Yuan W
    J Orthop Translat; 2023 Jan; 38():175-189. PubMed ID: 36439629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of Caveolae-Mediated Endocytic TβRI Degradation Results in Hypersensitivity of TGF-β/Smad Signaling in Osteogenesis Imperfecta.
    Shi C; Sun B; Wu H; Zhang R; Wu L; Guo L; Li C; Xi Y; Yuan W; Zhang Y; Xu G
    J Bone Miner Res; 2023 Jan; 38(1):103-118. PubMed ID: 36321807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium Ranelate Reduces the Fracture Incidence in a Growing Mouse Model of Osteogenesis Imperfecta.
    Shi C; Hu B; Guo L; Cao P; Tian Y; Ma J; Chen Y; Wu H; Hu J; Deng L; Zhang Y; Yuan W
    J Bone Miner Res; 2016 May; 31(5):1003-14. PubMed ID: 26679066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of TGF-β Increases Bone Volume and Strength in a Mouse Model of Osteogenesis Imperfecta.
    Greene B; Russo RJ; Dwyer S; Malley K; Roberts E; Serrielo J; Piepenhagen P; Cummings S; Ryan S; Zarazinski C; Uppuganti S; Bukanov N; Nyman JS; Cox MK; Liu S; Ibraghimov-Beskrovnaya O; Sabbagh Y
    JBMR Plus; 2021 Sep; 5(9):e10530. PubMed ID: 34532615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta.
    Infante A; Alcorta-Sevillano N; Macías I; Cabodevilla L; Medhat D; Lafaver B; Crawford TK; Phillips CL; Bueno AM; Sagastizabal B; Arroyo M; Campino A; Gerovska D; Araúzo-Bravo M; Gener B; Rodríguez CI
    Biomed Pharmacother; 2024 Jun; 175():116725. PubMed ID: 38744219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MOTS-c improves osteoporosis by promoting osteogenic differentiation of bone marrow mesenchymal stem cells via TGF-β/Smad pathway.
    Hu BT; Chen WZ
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7156-7163. PubMed ID: 30468456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myokine Irisin promotes osteogenesis by activating BMP/SMAD signaling via αV integrin and regulates bone mass in mice.
    Xue Y; Hu S; Chen C; He J; Sun J; Jin Y; Zhang Y; Zhu G; Shi Q; Rui Y
    Int J Biol Sci; 2022; 18(2):572-584. PubMed ID: 35002510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irisin promotes fracture healing by improving osteogenesis and angiogenesis.
    Kan T; He Z; Du J; Xu M; Cui J; Han X; Tong D; Li H; Yan M; Yu Z
    J Orthop Translat; 2022 Nov; 37():37-45. PubMed ID: 36196152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta.
    Cardinal M; Tys J; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
    Bone; 2019 Jul; 124():137-147. PubMed ID: 31051315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim).
    Balk ML; Bray J; Day C; Epperly M; Greenberger J; Evans CH; Niyibizi C
    Bone; 1997 Jul; 21(1):7-15. PubMed ID: 9213002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
    Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
    Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta.
    Berman AG; Wallace JM; Bart ZR; Allen MR
    Matrix Biol; 2016; 52-54():19-28. PubMed ID: 26707242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrine attenuates heterotopic ossification by suppressing TGF-β induced mesenchymal stromal cell migration and osteogenic differentiation.
    Mao D; Pan X; Rui Y; Li F
    Biomed Pharmacother; 2020 Jul; 127():110152. PubMed ID: 32559842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrafibrillar mineralization deficiency and osteogenesis imperfecta mouse bone fragility.
    Maghsoudi-Ganjeh M; Samuel J; Ahsan AS; Wang X; Zeng X
    J Mech Behav Biomed Mater; 2021 May; 117():104377. PubMed ID: 33636677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting TGF-β for treatment of osteogenesis imperfecta.
    Song IW; Nagamani SC; Nguyen D; Grafe I; Sutton VR; Gannon FH; Munivez E; Jiang MM; Tran A; Wallace M; Esposito P; Musaad S; Strudthoff E; McGuire S; Thornton M; Shenava V; Rosenfeld S; Huang S; Shypailo R; Orwoll E; Lee B
    J Clin Invest; 2022 Apr; 132(7):. PubMed ID: 35113812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of ring finger protein 11 regulating Akt signaling pathway to promote osteogenic differentiation of bone marrow mesenchymal stem cells].
    Deng W; Long T; Du Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2022 Jan; 36(1):102-110. PubMed ID: 35038807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schnurri-3 inhibition rescues skeletal fragility and vascular skeletal stem cell niche pathology in a mouse model of osteogenesis imperfecta.
    Xu R; Li N; Shi B; Li Z; Han J; Sun J; Yallowitz A; Bok S; Xiao S; Wu Z; Chen Y; Xu Y; Qin T; Lin Z; Zheng H; Shen R; Greenblatt M
    Res Sq; 2023 Jul; ():. PubMed ID: 37546916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compromised Exercise Capacity and Mitochondrial Dysfunction in the Osteogenesis Imperfecta Murine (oim) Mouse Model.
    Gremminger VL; Jeong Y; Cunningham RP; Meers GM; Rector RS; Phillips CL
    J Bone Miner Res; 2019 Sep; 34(9):1646-1659. PubMed ID: 30908713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice.
    Cardinal M; Dessain A; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
    Calcif Tissue Int; 2020 May; 106(5):494-508. PubMed ID: 32025752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.
    Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL
    Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.